POSITION: A PilOt Study of InducTion PARP InhibitiON in Ovarian Cancer
Active, no longer recruiting
Phase of Trial: Phase 0
Latest Information Update: 02 Mar 2017
At a glance
- Drugs Talazoparib (Primary)
- Indications Fallopian tube cancer; Ovarian cancer; Peritoneal cancer
- Focus Therapeutic Use
- Acronyms POSITION
- 23 Feb 2016 Status changed from recruiting to active, no longer recruiting as reported by ClinicalTrials.gov.
- 02 Jun 2015 Planned primary completion date changed from 1 Aug 2018 to 1 Jun 2018 as reported by ClinicalTrials.gov.
- 02 Jun 2015 Status changed from not yet recruiting to recruiting as reported by ClinicalTrials.gov.